检索结果 - Michael C. Burger

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival

    Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity a... 由 Sabrina Genßler, Michael C. Burger, Congcong Zhang, Sarah Oelsner, Iris Mildenberger, Marlies Wagner, Jörg Steinbach, Winfried S. Wels

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy

    CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy 由 Michael C. Burger, Congcong Zhang, Patrick N. Harter, A Romański, F Straßheimer, Christian Senft, Torsten Tonn, Joachim P. Steinbach, Winfried S. Wels

    出版 2019
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Interference with the HSF1/HSP70/BAG3 Pathway Primes Glioma Cells to Matrix Detachment and BH3 Mimetic–Induced Apoptosis

    Interference with the HSF1/HSP70/BAG3 Pathway Primes Glioma Cells to Matrix Detachment and BH3 Mimetic–Induced Apoptosis 由 Patrick Antonietti, Benedikt Linder, Stephanie Hehlgans, Iris Mildenberger, Michael C. Burger, Simone Fulda, Jörg Steinbach, Florian Geßler, Franz Rödel, Michel Mittelbronn, Donat Kögel

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma

    ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma 由 Congcong Zhang, Michael C. Burger, Lukas Jennewein, Sabrina Genßler, Kurt Schönfeld, Pia S. Zeiner, Elke Hattingen, Patrick N. Harter, Michel Mittelbronn, Torsten Tonn, Jörg Steinbach, Winfried S. Wels

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine

    Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine 由 Katharina J. Wenger, Marlies Wagner, Se-Jong You, Kea Franz, Patrick N. Harter, Michael C. Burger, Martin Voß, Michael Ronellenfitsch, Emmanouil Fokas, Joachim P. Steinbach, Oliver Bähr

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma

    AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma 由 Maja Strecker, Karolin Wlotzka, F Straßheimer, Bastian Roller, G. Ludmirski, Sven König, Jasmin Röder, Corinna Opitz, Tijna Alekseeva, Johanna Reul, Lisa Sevenich, Torsten Tonn, Winfried S. Wels, Jörg Steinbach, Christian J. Buchholz, Michael C. Burger

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma

    CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma 由 F Straßheimer, P Elleringmann, G. Ludmirski, Bastian Roller, Jadranka Macas, Tijna Alekseeva, Pınar Çakmak, Blerina Aliraj, Harald Krenzlin, Melanie Demes, Iris Mildenberger, Torsten Tonn, Klaus‐Josef Weber, Yvonne Reiss, Karl H. Plate, Andreas Weigert, Winfried S. Wels, Joachim P. Steinbach, Michael C. Burger

    出版 2025
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors

    Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors 由 Antje Wick, Oliver Bähr, Martin Schüler, Kristoffer Staal Rohrberg, Sant P. Chawla, Filip Janků, David Schiff, Volker Heinemann, Yoshitaka Narita, Heinz‐Josef Lenz, Masafumi Ikeda, Yuichi Ando, Wolfgang Wick, Joachim P. Steinbach, Michael C. Burger, Katharina J. Wenger, Ulrik Lassen, Kamalesh K. Sankhala, Cristiana Roggia, Isabelle Genvresse, Catya Munhoz, Christine Rentzsch, Susanne Reschke, Simon Langer, Markus Wagner, Stefan Kaulfuß, Charles L. Cai, Eleni Lagkadinou, Michael Jeffers, Carol E. Peña, Ghazaleh Tabatabai

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Data from Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors

    Data from Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors 由 Antje Wick, Oliver Bähr, Martin Schüler, Kristoffer Staal Rohrberg, Sant P. Chawla, Filip Janků, David Schiff, Volker Heinemann, Yoshitaka Narita, Heinz‐Josef Lenz, Masafumi Ikeda, Yuichi Ando, Wolfgang Wick, Joachim P. Steinbach, Michael C. Burger, Katharina J. Wenger, Ulrik Lassen, Kamalesh K. Sankhala, Cristiana Roggia, Isabelle Genvresse, Catya Munhoz, Christine Rentzsch, Susanne Reschke, Simon Langer, Markus Wagner, Stefan Kaulfuß, Charles M. Cai, Eleni Lagkadinou, Michael Jeffers, Carol E. Peña, Ghazaleh Tabatabai

    出版 2023
    获取全文
    Pré-impressão
    加到收藏夹
    Saved in:
  10. 10
    Data from Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors

    Data from Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors 由 Antje Wick, Oliver Bähr, Martin Schüler, Kristoffer Staal Rohrberg, Sant P. Chawla, Filip Janků, David Schiff, Volker Heinemann, Yoshitaka Narita, Heinz‐Josef Lenz, Masafumi Ikeda, Yuichi Ando, Wolfgang Wick, Joachim P. Steinbach, Michael C. Burger, Katharina J. Wenger, Ulrik Lassen, Kamalesh K. Sankhala, Cristiana Roggia, Isabelle Genvresse, Catya Munhoz, Christine Rentzsch, Susanne Reschke, Simon Langer, Markus Wagner, Stefan Kaulfuß, Charles M. Cai, Eleni Lagkadinou, Michael Jeffers, Carol E. Peña, Ghazaleh Tabatabai

    出版 2023
    获取全文
    Pré-impressão
    加到收藏夹
    Saved in:
  11. 11
    Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma

    Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma 由 Michael C. Burger, Marie-Thérèse Forster, A Romański, F Straßheimer, Jadranka Macas, Pia S. Zeiner, Eike Steidl, Stefanie Herkt, Katharina J. Weber, Jonathan Schupp, Jennifer H. Lun, Maja Strecker, Karolin Wlotzka, Pinar Cakmak, Corinna Opitz, Rosemol George, Iris Mildenberger, Paulina Nowakowska, Congcong Zhang, Jasmin Röder, Elvira Müller, Kristina Ihrig, Karl‐Josef Langen, Michael A. Rieger, Eva Herrmann, Halvard Bonig, Patrick N. Harter, Yvonne Reiss, Elke Hattingen, Franz Rödel, Karl H. Plate, Torsten Tonn, Christian Senft, Joachim P. Steinbach, Winfried S. Wels

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: